Methods for treating spinal cord injury with a compound that inhibits a NCCa-ATP channel
US7872048B2 · kind B2 · utility
17Cited by
32References
28Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 16, 2005 |
| Grant date | Jan 18, 2011 |
| Priority date | — |
| Expiry date | Jun 11, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to therapeutic compositions targeting the NCCa-ATP channel of an astrocyte, neuron or capillary endothelial cell and methods of using same. More specifically, antagonists of the NCCa-ATP channel are contemplated. The compositions are used to prevent cell death and to treat secondary damage associated with spinal cord injury.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.